COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 229 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2024. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $343,607 | -17.8% | 10,671 | -0.9% | 0.01% | -26.7% |
| Q1 2024 | $418,131 | +27.6% | 10,771 | +1.2% | 0.02% | +7.1% |
| Q4 2023 | $327,561 | +37.7% | 10,642 | 0.0% | 0.01% | +16.7% |
| Q3 2023 | $237,849 | +4.0% | 10,642 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $228,697 | -10.4% | 10,642 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $255,302 | +3.4% | 10,642 | 0.0% | 0.01% | -6.7% |
| Q4 2022 | $246,894 | +45.2% | 10,642 | 0.0% | 0.02% | +50.0% |
| Q3 2022 | $170,000 | -9.6% | 10,642 | +0.5% | 0.01% | -9.1% |
| Q2 2022 | $188,000 | -13.4% | 10,593 | -0.6% | 0.01% | +10.0% |
| Q1 2022 | $217,000 | +9.6% | 10,656 | +0.4% | 0.01% | +11.1% |
| Q4 2021 | $198,000 | -5.3% | 10,615 | +0.2% | 0.01% | -18.2% |
| Q3 2021 | $209,000 | -16.4% | 10,593 | 0.0% | 0.01% | -15.4% |
| Q2 2021 | $250,000 | -0.4% | 10,593 | 0.0% | 0.01% | -13.3% |
| Q1 2021 | $251,000 | – | 10,593 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |